Gain Actionable Insights from Our Evidence-Based Industry Expertise.
Our approach reveals intentional parallels to your brand, offering strategic guidance drawn from real-world experiences.
- Brand Communications
- Industry Observations
- 4 Day Work Week
While the premise/promise/proof (PPP) approach to brand positioning development is well known and still commonly used, it does not allow brands to garner the full benefits of a true storytelling approach. Whether its use is related more to tradition, habit, and inertia or to a lack of confidence in a team’s ability to craft a...
read more >
read more >
When we’re conducting positioning work with Clients, we often hear a blanket statement that a pharmaceutical/ biotechnology brand cannot be successfully positioned based on its mechanism of action (MOA). It’s likely that repeated comments from physicians to the effect of, “I don’t care how your drug works. I only care that it works.”, have made...
read more >
read more >
As pharmaceutical manufacturers increasingly focus their corporate commitment within a limited number of therapeutic areas and disease states, their marketers face greater complexity and new commercial challenges that may ultimately limit their success. The marketers entrusted with launching the next treatment within a therapeutic franchise are frequently not given the latitude needed to develop the...
read more >
read more >
Most products being launched in Oncology and Immunology these days are “pipeline in a product” assets. In fact, the average number of indications for each new product in development has increased steadily since 2014. This shift has led to a dramatic impact on positioning development, with Brand Teams often more focused on developing “positioning” that...
read more >
read more >
While the premise/promise/proof (PPP) approach to brand positioning development is well known and still commonly used, it does not allow brands to garner the full benefits of a true storytelling approach. Whether its use is related more to tradition, habit, and inertia or to a lack of confidence in a team’s ability to craft a...
read more >
read more >
When we’re conducting positioning work with Clients, we often hear a blanket statement that a pharmaceutical/ biotechnology brand cannot be successfully positioned based on its mechanism of action (MOA). It’s likely that repeated comments from physicians to the effect of, “I don’t care how your drug works. I only care that it works.”, have made...
read more >
read more >
As pharmaceutical manufacturers increasingly focus their corporate commitment within a limited number of therapeutic areas and disease states, their marketers face greater complexity and new commercial challenges that may ultimately limit their success. The marketers entrusted with launching the next treatment within a therapeutic franchise are frequently not given the latitude needed to develop the...
read more >
read more >
Most products being launched in Oncology and Immunology these days are “pipeline in a product” assets. In fact, the average number of indications for each new product in development has increased steadily since 2014. This shift has led to a dramatic impact on positioning development, with Brand Teams often more focused on developing “positioning” that...
read more >
read more >
We’ve had the opportunity to participate in or examine our fair share of pharma/ biotechnology brand launches over the years. What sets apart most successful product launches from sub-optimal product launches is the ability to address one central question your physicians will almost certainly ask at approval. What is the one patient type that will...
read more >
read more >
Today’s commercial lead launching the next big advance in a specific category too often circulates exclusively in rarified air. To put it a different way, their views about the market, prescribers, patients, and their product are almost exclusively shaped by a small group of key medical experts who tend to specialize exclusively in the condition...
read more >
read more >
Brand Teams have recently become intoxicated with idea of positioning themselves as a ‘challenger brand,’ with the expressed goal of becoming the disruptor in an established category. This approach is frequently built on the logic that the presence of a unique endpoint or a numerical improvement in an established endpoint from the pivotal trial(s) can...
read more >
read more >
For those that aren’t familiar with brand positioning, it is the act of creating a perception of your product in the mind of your target audience that differentiates it from its competition. Regardless of the positioning development and validation process you employ, it’s critical for marketers to understand the culture of their respective company to...
read more >
read more >
The importance of proper patient identification at launch cannot be overstated. The feedback from the initial patients prescribed your product is one of the most important factors in determining how physicians perceive its utility vs. the competition. Multiply this by all your target physicians, and these initial experiences have a huge impact on your initial...
read more >
read more >
As the Summer of 2023 enters full swing, the world has officially shaken off the remaining vestiges of the pandemic years. While we are all enjoying this return to normalcy, it’s critical that those of us who have the privilege and responsibility to craft policies for the workforce don’t forget some of the lessons we...
read more >
read more >
More Brand Communications Posts >
Our evidence-based approach provides us with a unique lens to observe and provide insights and commentary on industry news and common client experiences. Please note that any similarities of the events and insights provided here to your current brand situation are purely intentional and should not be considered coincidental.